2020-2025 Global Vigabatrin Market Report - Production and Consumption Professional Analysis (Impact of COVID-19)
- 85291
- 18-May
- Healthcare
- 107
- MRR
-
Report Details
Vigabatrin is a GABA derivative that is used in combination with other agents as therapy of refractory complex partial seizures and as monotherapy for infantile spasms. Vigabatrin is associated with a paradoxical decrease in serum enzyme levels during therapy, explained by its direct inhibition of aminotransferase activity. Vigabatrin has not been convincingly linked to cases of clinically apparent liver injury, but was linked to a fatal case of Reye syndrome in a child with severe developmental delay. This report elaborates the market size, market characteristics, and market growth of the Vigabatrin industry, and breaks down according to the type, application, and consumption area of Vigabatrin. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry. In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Vigabatrin in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19. In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy. Key players in the global Vigabatrin market covered in Chapter 13: Amneal Pharmaceuticals Lundbeck Sanofi Par Pharmaceuticals ORPHELIA Pharma SAS In Chapter 6, on the basis of types, the Vigabatrin market from 2015 to 2025 is primarily split into: Tablets Powder In Chapter 7, on the basis of applications, the Vigabatrin market from 2015 to 2025 covers: Epilepsy Seizure Prevention Seizures Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5: United States Europe China Japan India Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12: North America (Covered in Chapter 8) United States Canada Mexico Europe (Covered in Chapter 9) Germany UK France Italy Spain Others Asia-Pacific (Covered in Chapter 10) China Japan India South Korea Southeast Asia Others Middle East and Africa (Covered in Chapter 11) Saudi Arabia UAE South Africa Others South America (Covered in Chapter 12) Brazil Others Years considered for this report: Historical Years: 2015-2019 Base Year: 2019 Estimated Year: 2020 Forecast Period: 2020-2025
-
Table Of Content
Table of Content 1 Vigabatrin Market - Research Scope 1.1 Study Goals 1.2 Market Definition and Scope 1.3 Key Market Segments 1.4 Study and Forecasting Years 2 Vigabatrin Market - Research Methodology 2.1 Methodology 2.2 Research Data Source 2.2.1 Secondary Data 2.2.2 Primary Data 2.2.3 Market Size Estimation 2.2.4 Legal Disclaimer 3 Vigabatrin Market Forces 3.1 Global Vigabatr
-
Inquiry Before Buying
-
Request Sample